Literature DB >> 17098689

Tandem mass neonatal screening in Taiwan--report from one center.

Hsiang-Po Huang1, Kai-Lin Chu, Yin-Hsiu Chien, Ming-Lee Wei, Shu-Tzu Wu, Shiao-Fang Wang, Wuh-Liang Hwu.   

Abstract

BACKGROUND/
PURPOSE: Neonatal screening using tandem mass spectrometry (MS/MS) started in Taiwan in 2000. We evaluated the efficacy of this system by analyzing the frequency of diseases and the outcome of the patients identified.
METHODS: Between August 2001 and July 2004, 199, 922 neonates were screened for 10 amino acids and acylcarnitines using MS/MS in a single center.
RESULTS: In total, 29 cases of inborn errors of metabolism were detected. The overall prevalence was one per 6894 births. The most common inborn error found was 3-methylcrotonyl CoA carboxylase deficiency (10 cases, 34.5%), but none of the cases needed aggressive treatment. There were two cases of type I glutaric aciduria, two cases of maple syrup urine disease, and one case of type II citrullinemia, and early therapeutic intervention was effective for all of them.
CONCLUSION: We found that MS/MS neonatal screening was valuable in the early diagnosis of severe and treatable inborn errors of metabolism such as organic acidemias and urea cycle disorders. It also detected less severe disorders that required only observation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098689     DOI: 10.1016/S0929-6646(09)60173-X

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  11 in total

Review 1.  Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.

Authors:  Martin Lindner; Georg F Hoffmann; Dietrich Matern
Journal:  J Inherit Metab Dis       Date:  2010-04-07       Impact factor: 4.982

2.  Newborn screening in the Asia Pacific region.

Authors:  Carmencita D Padilla; Bradford L Therrell
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

3.  Newborn Screening for Vitamin B6 Non-responsive Classical Homocystinuria: Systematical Evaluation of a Two-Tier Strategy.

Authors:  Jürgen G Okun; Hongying Gan-Schreier; Tawfeq Ben-Omran; Kathrin V Schmidt; Junmin Fang-Hoffmann; Gwendolyn Gramer; Ghassan Abdoh; Noora Shahbeck; Hilal Al Rifai; Abdul Latif Al Khal; Gisela Haege; Chuan-Chi Chiang; David C Kasper; Bridget Wilcken; Peter Burgard; Georg F Hoffmann
Journal:  JIMD Rep       Date:  2016-06-21

4.  Fatty Acid oxidation disorders in a chinese population in taiwan.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Mei-Chyn Chao; Li-Chu Chen; Li-Hsin Chen; Chun-Ching Chien; Hui-Chen Ho; Jeng-Hung Suen; Wuh-Liang Hwu
Journal:  JIMD Rep       Date:  2013-05-23

5.  Hypermethioninemia in Campania: Results from 10 years of newborn screening.

Authors:  Guglielmo R D Villani; Lucia Albano; Marianna Caterino; Daniela Crisci; Silvia Di Tommaso; Simona Fecarotta; Maria Grazia Fisco; Giulia Frisso; Giovanna Gallo; Cristina Mazzaccara; Emanuela Marchese; Antonio Nolano; Giancarlo Parenti; Rita Pecce; Adriana Redi; Francesco Salvatore; Pietro Strisciuglio; Maria Grazia Turturo; Fabiana Vallone; Margherita Ruoppolo
Journal:  Mol Genet Metab Rep       Date:  2019-10-11

Review 6.  Neuropsychological attributes of urea cycle disorders: A systematic review of the literature.

Authors:  Susan E Waisbren; Arianna K Stefanatos; Teresa M Y Kok; Burcu Ozturk-Hismi
Journal:  J Inherit Metab Dis       Date:  2019-08-01       Impact factor: 4.982

7.  High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.

Authors:  Hui-An Chen; Rai-Hseng Hsu; Pin-Wen Chen; Ni-Chung Lee; Pao-Chin Chiu; Wuh-Liang Hwu; Yin-Hsiu Chien
Journal:  Mol Genet Metab Rep       Date:  2022-07-28

8.  Web-based newborn screening system for metabolic diseases: machine learning versus clinicians.

Authors:  Wei-Hsin Chen; Sheau-Ling Hsieh; Kai-Ping Hsu; Han-Ping Chen; Xing-Yu Su; Yi-Ju Tseng; Yin-Hsiu Chien; Wuh-Liang Hwu; Feipei Lai
Journal:  J Med Internet Res       Date:  2013-05-23       Impact factor: 5.428

9.  ETF-QO Mutants Uncoupled Fatty Acid β-Oxidation and Mitochondrial Bioenergetics Leading to Lipid Pathology.

Authors:  Suphannee Chokchaiwong; Yung-Ting Kuo; Sung-Po Hsu; Yi-Ching Hsu; Shih-Hsiang Lin; Wen-Bin Zhong; Yung-Feng Lin; Shu-Huei Kao
Journal:  Cells       Date:  2019-01-31       Impact factor: 6.600

Review 10.  Clinical manifestations and management of fatty acid oxidation disorders.

Authors:  J Lawrence Merritt; Erin MacLeod; Agnieszka Jurecka; Bryan Hainline
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.